Correction to: Ann Surg Oncol 10.1245/s10434-018-6470-1
In the original article John F. Thompson was inadvertently omitted as an author. The author list is updated as shown in this correction.
. 2018 Jun 26;25(Suppl 3):991. doi: 10.1245/s10434-018-6612-5
Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study
Marc D Moncrieff
1,✉, David Gyorki
2, Robyn Saw
3, Andrew J Spillane
3, John F Thompson
3, Howard Peach
4, Deemesh Oudit
5, Jenny Geh
6, Peter Dziewulsk
7, Ewan Wilson
8, Paolo Matteucci
9, Rowan Pritchard-Jones
10, Roger Olofsson Bagge
11, Frances C Wright
12, Nic Crampton
13, Oliver Cassell
14, Navid Jallali
15, Adam Berger
16, John Kelly
17, Stephen Hamilton
18, Amer Durrani
19, Serigne Lo
3,20, Elizabeth Paton
3,20, Michael A Henderson
2
Marc D Moncrieff, MD FRCS(Plast.)
1Norfolk & Norwich University Hospital, Norwich, UK
Find articles by Marc D Moncrieff
David Gyorki, FRACS
2Peter MacCallum Cancer Centre, Melbourne, Australia
Find articles by David Gyorki
Andrew J Spillane, FRACS
3Melanoma Institute Australia, Sydney, Australia
Find articles by Andrew J Spillane
John F Thompson, MD, FRACS, FACS
3Melanoma Institute Australia, Sydney, Australia
Find articles by John F Thompson
Peter Dziewulsk, FRCS(Plast.)
7St Andrew’s Centre for Burns & Plastic Surgery, Chelmsford, UK
Find articles by Peter Dziewulsk
Paolo Matteucci, FRCS(Plast.)
9Hull & East Yorkshire NHS Trust, Hull, UK
Find articles by Paolo Matteucci
Rowan Pritchard-Jones, FRCS(Plast.)
10Mersey Centre for Burns & Plastic Surgery, Liverpool, UK
Find articles by Rowan Pritchard-Jones
Roger Olofsson Bagge, MD, PhD
11Sahlgrenska University Hospital, Göteborg, Sweden
Find articles by Roger Olofsson Bagge
Frances C Wright, MD, M.Ed
12Sunnybrook Health Sciences Centre, Toronto, Canada
Find articles by Frances C Wright
Nic Crampton, FRACS
13Gold Coast Melanoma Clinic, Queensland, Australia
Find articles by Nic Crampton
Oliver Cassell, FRCS(Plast.)
14Oxford University Hospitals NHS Trust, Oxford, UK
Find articles by Oliver Cassell
Navid Jallali, FRCS(Plast.)
15Imperial Hospital NHS Trust, London, UK
Find articles by Navid Jallali
Stephen Hamilton, FRCS(Plast.)
18Royal Free Hospital NHS Trust, London, UK
Find articles by Stephen Hamilton
Amer Durrani, FRCS(Plast.)
19Cambridge University Hospitals, Cambridge, UK
Find articles by Amer Durrani
Serigne Lo, PhD
3Melanoma Institute Australia, Sydney, Australia
20Australia & New Zealand Melanoma Trials Group, North Sydney, Australia
Find articles by Serigne Lo
Elizabeth Paton, MSc
3Melanoma Institute Australia, Sydney, Australia
20Australia & New Zealand Melanoma Trials Group, North Sydney, Australia
Find articles by Elizabeth Paton
Michael A Henderson, FRACS
2Peter MacCallum Cancer Centre, Melbourne, Australia
Find articles by Michael A Henderson
1Norfolk & Norwich University Hospital, Norwich, UK
2Peter MacCallum Cancer Centre, Melbourne, Australia
3Melanoma Institute Australia, Sydney, Australia
4Leeds Teaching Hospitals, Leeds, UK
5Christie NHS Trust, Manchester, UK
6Guy’s & St Thomas’s NHS Trust, London, UK
7St Andrew’s Centre for Burns & Plastic Surgery, Chelmsford, UK
8North Bristol NHS Trust, Bristol, UK
9Hull & East Yorkshire NHS Trust, Hull, UK
10Mersey Centre for Burns & Plastic Surgery, Liverpool, UK
11Sahlgrenska University Hospital, Göteborg, Sweden
12Sunnybrook Health Sciences Centre, Toronto, Canada
13Gold Coast Melanoma Clinic, Queensland, Australia
14Oxford University Hospitals NHS Trust, Oxford, UK
15Imperial Hospital NHS Trust, London, UK
16Jefferson University Hospitals, Philadelphia, USA
17The Alfred Hospital, Melbourne, Australia
18Royal Free Hospital NHS Trust, London, UK
19Cambridge University Hospitals, Cambridge, UK
20Australia & New Zealand Melanoma Trials Group, North Sydney, Australia
✉
Corresponding author.
Issue date 2018.
© Society of Surgical Oncology 2018
PMCID: PMC6829792 PMID: 29947003
This corrects the article "1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study" on page 2541.